Geode Capital Management, LLC Beam Therapeutics Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,807,683 shares of BEAM stock, worth $45.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,807,683
Previous 1,729,581 4.52%
Holding current value
$45.7 Million
Previous $40.5 Million 9.29%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$22.57 - $33.14 $1.76 Million - $2.59 Million
78,102 Added 4.52%
1,807,683 $44.3 Million
Q2 2024

Aug 09, 2024
BUY
$21.22 - $32.66 $1.97 Million - $3.03 Million
92,859 Added 5.67%
1,729,581 $40.5 Million
Q1 2024

May 13, 2024
BUY
$23.46 - $45.07 $1.44 Million - $2.77 Million
61,443 Added 3.9%
1,636,722 $54.1 Million
Q4 2023

Feb 13, 2024
BUY
$17.69 - $30.76 $1.88 Million - $3.28 Million
106,531 Added 7.25%
1,575,279 $42.9 Million
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $3.33 Million - $4.69 Million
144,573 Added 10.92%
1,468,748 $35.3 Million
Q2 2023

Aug 11, 2023
BUY
$29.32 - $35.99 $3.57 Million - $4.39 Million
121,846 Added 10.13%
1,324,175 $42.3 Million
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $1.49 Million - $2.41 Million
49,389 Added 4.28%
1,202,329 $36.8 Million
Q4 2022

Feb 13, 2023
BUY
$36.73 - $51.6 $1.78 Million - $2.5 Million
48,465 Added 4.39%
1,152,940 $45.1 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $5.46 Million - $9.65 Million
137,252 Added 14.19%
1,104,475 $52.6 Million
Q2 2022

Aug 12, 2022
BUY
$29.86 - $62.36 $3.15 Million - $6.58 Million
105,529 Added 12.25%
967,223 $37.4 Million
Q1 2022

May 13, 2022
BUY
$53.73 - $82.16 $704,131 - $1.08 Million
13,105 Added 1.54%
861,694 $49.4 Million
Q4 2021

Feb 11, 2022
BUY
$68.02 - $99.06 $1.75 Million - $2.55 Million
25,695 Added 3.12%
848,589 $67.6 Million
Q3 2021

Nov 12, 2021
BUY
$84.37 - $133.6 $11.6 Million - $18.4 Million
137,620 Added 20.08%
822,894 $71.6 Million
Q2 2021

Aug 13, 2021
BUY
$64.12 - $128.71 $5.7 Million - $11.4 Million
88,869 Added 14.9%
685,274 $88.2 Million
Q1 2021

May 12, 2021
BUY
$71.28 - $120.75 $4.66 Million - $7.9 Million
65,440 Added 12.32%
596,405 $47.7 Million
Q4 2020

Feb 12, 2021
BUY
$22.24 - $95.63 $1.92 Million - $8.25 Million
86,275 Added 19.4%
530,965 $43.3 Million
Q3 2020

Nov 13, 2020
BUY
$19.0 - $30.57 $4.45 Million - $7.16 Million
234,161 Added 111.23%
444,690 $10.9 Million
Q2 2020

Aug 13, 2020
BUY
$15.26 - $28.66 $2.12 Million - $3.98 Million
138,963 Added 194.17%
210,529 $5.89 Million
Q1 2020

May 14, 2020
BUY
$13.31 - $29.2 $952,543 - $2.09 Million
71,566 New
71,566 $1.29 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email